Clinical Scorecard: The Real-world Impact of Suprachoroidal Triamcinolone Acetonide for Uveitic Macular Edema
At a Glance
| Category | Detail |
|---|---|
| Condition | Uveitic Macular Edema (UME) |
| Key Mechanisms | Suprachoroidal delivery of triamcinolone acetonide for sustained release and control of inflammation. |
| Target Population | Patients aged 18 years or older with non-infectious UME, particularly those with a history of glaucoma or ocular hypertension. |
| Care Setting | Clinical practice, utilizing data from the American Academy of Ophthalmology’s IRIS Registry. |
Key Highlights
- Single injection of suprachoroidal triamcinolone acetonide provides durable relief from UME.
- Low incidence of significant IOP elevation even in patients with a history of glaucoma.
- Effective management of UME with minimal need for additional treatments post-injection.
- Follow-up recommended at 1, 3, 6, and every 3 months to monitor IOP.
Guideline-Based Recommendations
Diagnosis
- Diagnosis of non-infectious UME confirmed through clinical evaluation.
Management
- Consider suprachoroidal triamcinolone acetonide for treatment, especially in patients at risk for elevated IOP.
Monitoring & Follow-up
- Monitor IOP at 1, 3, 6, and every 3 months thereafter.
Risks
- Potential for increased IOP, particularly in patients with a history of glaucoma or ocular hypertension.
Patient & Prescribing Data
785 patients analyzed, predominantly women (55%), with 82% having posterior uveitis.
Suprachoroidal triamcinolone acetonide is safe and effective, with manageable IOP increases.
Clinical Best Practices
- Assess patient history for glaucoma or ocular hypertension before treatment.
- Educate patients on the potential risks of IOP elevation.
- Utilize real-world data to inform treatment decisions and follow-up care.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
